Date: Monday, June 4, 2018
Session Time: 6:00pm-7:00pm
Presentation Time: 6:00pm-7:00pm
Location: Hall 4EF
- Utility of “High-Dose” Ganciclovir in High Viral Load CMV Infection in Transplant Recipients.
- Evaluation of Long Term Outcome After Living Donor Liver Transplantation in Sequential 653 Recipients with or without Viral Infection: Is HBV & HCV Co-Infection Better Than the Monoinfection? A Single Center Retrospective Analysis.
Infectious complications under immunosuppressive therapy are inevitable problems. Viral infection (include reactivation) occurs at a certain frequency even if immunosuppressive agents are totally adjusted by Pharmacokinetic Study. We focused our attention on CD8 T cell directly related to anti-viral response. In this study, PD analysis was performed on CD4 and CD8 T cells and the relevance to viral infection was examined.
PD analysis was conducted by CFSE-based T cell proliferation assay after separation of CD4 and CD8 T cells. The 50% inhibitory concentration (IC50) and the percentage of T cell proliferation values at the lower plateau (Bottom) were considered as a criterion of sensitivity to calcineurin inhibitor. Cut off levels of Bottom was 25%.
(1) Retrospective Study
Bottom and IC50 were calculated from the sigmoid curve in 9 kidney transplant recipients with viral infection and 10 without infection, which were retrospectively compared with clinical findings.
(2) Prospective Study
PD analysis-based immunosuppressive therapy was performed in 12 patients. In patients with low Bottom (=high sensitivity to CNI), CNI dose was reduced from the early postoperative day. Viral infection was examined up to 4 months after transplantation. For patients with high Bottom , the standard immunosuppressive regimen was used.
(1) Analysis of CD4 T cells showed no significant trends in Bottom and IC 50 for viral infection. Regarding CD8 T cells, viral infection was significantly related to a low Bottom of TAC. (P=0.013)
(2) High sensitivity to both CSA and TAC was observed in 2 patients. CNI was reduced to once a day from day 10. Two patients showed high sensitivity to either CSA or TAC. One patient reduced the CNI dose on day 10, while the other was treated with a lower sensitivity drug at a standard dose. The remaining 8 patients with low sensitivity were given CNI at a standard dose. As a result of PD analysis based immunosuppression, the prevalence of viral infection was reduced (0/12, 0%), compared with conventional treatment (23/105, 21%).
Immunosuppressive therapy based on PD analysis targeting CD8 T cells was considered effective for preventing post-transplant viral infection. PD analysis can be used to improve the incompleteness of PK study, leading to implement of individualized immunosuppression.
CITATION INFORMATION: Matsuoka Y., Iwasaki K., Miwa Y., Horimi K., Uchida K., Kobayashi T. Once Daily CNI Administration Based on Pharmacodynamic Analysis for Preventing Viral Infection Am J Transplant. 2017;17 (suppl 3).
To cite this abstract in AMA style:Matsuoka Y, Iwasaki K, Miwa Y, Horimi K, Uchida K, Kobayashi T. Once Daily CNI Administration Based on Pharmacodynamic Analysis for Preventing Viral Infection [abstract]. https://atcmeetingabstracts.com/abstract/once-daily-cni-administration-based-on-pharmacodynamic-analysis-for-preventing-viral-infection/. Accessed April 7, 2020.
« Back to 2018 American Transplant Congress